ArticleJournal for immunotherapy of cancer2023

ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers.

Zheng-Zheng Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.